Nature's Sunshine Reports Third Quarter 2024 Results
Nature's Sunshine (NATR) reported Q3 2024 results with net sales up 3% to $114.6 million compared to $111.2 million in the same year-ago quarter. GAAP net income increased to $4.3 million, or $0.23 per diluted share, up from $2.8 million, or $0.15 per share. Adjusted EBITDA rose 5% to $10.7 million.
The company saw strong customer growth in Japan, Taiwan, and Central Europe, though faced headwinds in China. Gross profit margin decreased to 71.3% from 73.1%. The company raised its full-year 2024 guidance, now expecting net sales between $443-448 million and adjusted EBITDA of $40-42 million.
Nature's Sunshine (NATR) ha riportato i risultati del terzo trimestre 2024 con vendite nette in aumento del 3%, raggiungendo 114,6 milioni di dollari rispetto a 111,2 milioni nello stesso trimestre dell'anno precedente. Il reddito netto GAAP è aumentato a 4,3 milioni di dollari, ovvero 0,23 dollari per azione diluita, in crescita rispetto a 2,8 milioni di dollari, ovvero 0,15 dollari per azione. L'EBITDA rettificato è salito del 5%, raggiungendo 10,7 milioni di dollari.
L'azienda ha registrato una forte crescita dei clienti in Giappone, Taiwan e Europa Centrale, anche se ha affrontato difficoltà in Cina. Il margine di profitto lordo è diminuito al 71,3% rispetto al 73,1% precedente. L'azienda ha alzato le sue previsioni per l'intero anno 2024, ora prevedendo vendite nette tra 443 e 448 milioni di dollari e un EBITDA rettificato di 40-42 milioni di dollari.
Nature's Sunshine (NATR) reportó los resultados del tercer trimestre de 2024 con ingresos netos en aumento del 3% a 114,6 millones de dólares en comparación con 111,2 millones en el mismo trimestre del año anterior. El ingreso neto según GAAP aumentó a 4,3 millones de dólares, o 0,23 dólares por acción diluida, subiendo desde 2,8 millones de dólares, o 0,15 dólares por acción. El EBITDA ajustado creció un 5% alcanzando 10,7 millones de dólares.
La compañía vio un fuerte crecimiento de clientes en Japón, Taiwán y Europa Central, aunque enfrentó dificultades en China. El margen de utilidad bruta disminuyó al 71,3% desde el 73,1%. La empresa elevó su pronóstico para todo el año 2024, ahora esperando ingresos netos entre 443 y 448 millones de dólares y un EBITDA ajustado de 40-42 millones de dólares.
Nature's Sunshine (NATR)는 2024년 3분기 실적을 보고하며 순매출이 3% 증가하여 1억 1460만 달러에 달했으며, 이는 작년 동기 1억 1120만 달러에 비해 증가한 수치입니다. GAAP 기준 순이익은 430만 달러, 즉 희석주당 0.23달러로 증가했으며, 이는 280만 달러 또는 주당 0.15달러에서 상승한 것입니다. 조정 EBITDA는 5% 증가하여 1070만 달러에 이릅니다.
회사는 일본, 대만, 중앙유럽에서 강력한 고객 성장을 보았으나, 중국에서는 어려움을 겪었습니다. 총 이익률은 73.1%에서 71.3%로 감소했습니다. 회사는 2024년 전체 연간 가이던스를 상향 조정하여 순매출을 4억 4300만에서 4억 4800만 달러 사이, 조정 EBITDA는 4000만에서 4200만 달러로 예상하고 있습니다.
Nature's Sunshine (NATR) a publié les résultats du troisième trimestre 2024, avec des ventes nettes en hausse de 3% à 114,6 millions de dollars contre 111,2 millions lors du même trimestre l'année précédente. Le bénéfice net selon les normes GAAP a augmenté à 4,3 millions de dollars, soit 0,23 dollar par action diluée, contre 2,8 millions de dollars, soit 0,15 dollar par action. L'EBITDA ajusté a augmenté de 5% pour atteindre 10,7 millions de dollars.
L'entreprise a connu une forte croissance de sa clientèle au Japon, à Taïwan et en Europe centrale, mais a rencontré des difficultés en Chine. La marge brute est passée de 73,1% à 71,3%. L'entreprise a relevé ses prévisions pour l'ensemble de l'année 2024, s'attendant désormais à des ventes nettes comprises entre 443 et 448 millions de dollars et un EBITDA ajusté de 40 à 42 millions de dollars.
Nature's Sunshine (NATR) berichtete über die Q3 2024 Ergebnisse mit netto Verkäufen, die um 3% auf 114,6 Millionen Dollar gestiegen sind im Vergleich zu 111,2 Millionen Dollar im gleichen Quartal des Vorjahres. Der GAAP Nettogewinn stieg auf 4,3 Millionen Dollar oder 0,23 Dollar pro verwässerter Aktie, verglichen mit 2,8 Millionen Dollar oder 0,15 Dollar pro Aktie. Das bereinigte EBITDA stieg um 5% auf 10,7 Millionen Dollar.
Das Unternehmen verzeichnete ein starkes Kundenwachstum in Japan, Taiwan und Mitteleuropa, sah sich jedoch in China mit Herausforderungen konfrontiert. Die Bruttomarge sank von 73,1% auf 71,3%. Das Unternehmen hob die Prognose für das Gesamtjahr 2024 an und erwartet nun Nettoverkäufe zwischen 443 und 448 Millionen Dollar sowie ein bereinigtes EBITDA von 40 bis 42 Millionen Dollar.
- Net sales increased 3% to $114.6 million (4% in constant currency)
- GAAP net income rose to $4.3 million from $2.8 million year-over-year
- Adjusted EBITDA increased 5% to $10.7 million
- Company raised full-year guidance for both revenue and EBITDA
- Strong cash position with $78.7 million and zero debt
- Gross profit margin declined to 71.3% from 73.1%
- Operating income decreased to $5.3 million from $5.8 million
- North America segment sales declined 3.3%
- Volume incentives increased to 31.0% from 30.7% of net sales
Insights
Nature's Sunshine's Q3 results show modest growth with
The company's balance sheet remains solid with
LEHI, Utah, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the third quarter ended September 30, 2024.
Third Quarter 2024 Financial Summary vs. Same Year-Ago Quarter
- Net sales were up
3% to$114.6 million compared to$111.2 million (up4% in constant currency). - GAAP net income attributable to common shareholders was
$4.3 million , or$0.23 per diluted common share, compared to$2.8 million , or$0.15 per diluted common share. - Adjusted EBITDA was up
5% to$10.7 million compared to$10.3 million .
Management Commentary
“The third quarter delivered the highest sales volume this year, with
“We are excited about the actions we’ve taken to advance our strategic agenda and remain confident that our approach will allow us to attract and retain more customers, drive profitable growth, and build shareholder value.”
Third Quarter 2024 Financial Results
| Net Sales by Operating Segment(Amounts in Thousands) | |||||||||||||||
| Three Months Ended September 30, 2024 | Three Months Ended September 30, 2023 | Percent Change | Impact of Currency Exchange | Percent Change Excluding Impact of Currency | |||||||||||
| Asia | $ | 55,293 | $ | 52,218 | 5.9 | % | $ | (1,418 | ) | 8.6 | % | ||||
| Europe | 19,615 | 18,769 | 4.5 | 302 | 2.9 | ||||||||||
| North America | 33,631 | 34,792 | (3.3 | ) | (46 | ) | (3.2 | ) | |||||||
| Latin America and Other | 6,076 | 5,423 | 12.0 | (136 | ) | 14.5 | |||||||||
| $ | 114,615 | $ | 111,202 | 3.1 | % | $ | (1,298 | ) | 4.2 | % | |||||
Net sales in the third quarter increased
Gross profit margin in the third quarter decreased to
Volume incentives as a percentage of net sales were
Selling, general and administrative expenses ("SG&A") in the third quarter were
Operating income in the third quarter decreased to
Other income, net, in the third quarter of 2024 was
GAAP net income attributable to common shareholders increased to
Adjusted EBITDA in the third quarter increased
Balance Sheet and Cash Flow
Net cash provided by operating activities was
Outlook
Nature's Sunshine now expects full year 2024 net sales to range between
Conference Call
The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its third quarter of 2024 results.
Date: Thursday, November 7, 2024
Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)
Toll-free dial-in number: 1-800-717-1738
International dial-in number: 1-646-307-1865
Conference ID: 03533
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.
The conference call will be broadcast live and available for replay here and via the Events section of the Nature’s Sunshine website here.
A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through November 21, 2024.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 1103533
About Nature’s Sunshine Products
Nature’s Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the company can be obtained at its website, www.naturessunshine.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans, strategies and financial results, including expected improvements in gross profit and gross margin. All statements (other than statements of historical fact) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following:
- extensive government regulations to which the Company’s products, business practices and manufacturing activities are subject;
- registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;
- legal challenges to the Company’s direct selling program or to the classification of its independent consultants;
- laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;
- liabilities and obligations arising from improper activity by the Company’s independent consultants;
- product liability claims;
- impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;
- the Company’s ability to attract and retain independent consultants;
- the loss of one or more key independent consultants who have a significant sales network;
- potential for increased liability and compliance costs relating to the Company’s joint venture for operations in China with Fosun Industrial Co., Ltd.;
- the effect of fluctuating foreign exchange rates;
- failure of the Company’s independent consultants to comply with advertising laws;
- changes to the Company’s independent consultants' compensation plans;
- geopolitical issues and conflicts;
- negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company’s customers to purchase products;
- risks associated with the manufacturing of the Company’s products;
- supply chain disruptions, manufacturing interruptions or delays, or the failure to accurately forecast customer demand;
- failure to timely and effectively obtain shipments of products from our manufacturers and deliver products to our independent consultants and customers;
- world-wide slowdowns and delays related to supply chain, ingredient shortages and logistical challenges;
- uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto;
- changes in tax laws, treaties or regulations, or their interpretation;
- failure to maintain an effective system of internal controls over financial reporting;
- cybersecurity threats and exposure to data loss;
- the storage, processing, and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;
- reliance on information technology infrastructure; and
- the sufficiency of trademarks and other intellectual property rights.
These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Form 10-Q.
All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release.
Non-GAAP Financial Measures
We have included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning non-GAAP net income, adjusted EBITDA and net sales excluding the impact of foreign currency exchange fluctuations.
We utilize the non-GAAP measures of non-GAAP net income and adjusted EBITDA in the evaluation of our operations and believe that these measures are useful indicators of our ability to fund our business. These non-GAAP financial measures should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income (loss) as an indicator of our operating performance.
Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature’s Sunshine Products’ performance in relation to other companies. We have included a reconciliation of net income, the most comparable GAAP measure, to adjusted EBITDA. We have also included a reconciliation of GAAP net income to non-GAAP net income and non-GAAP adjusted EPS, in the attached financial tables.
Net sales in local currency removes, from net sales in U.S. dollars, the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries. This is accomplished by translating the current period's net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period.
We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. Net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.
With respect to our adjusted EBITDA outlook for the full year 2024, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, we are unable to assess the probable significance of the unavailable information, which could have a material impact on our future GAAP financial results.
Investor Relations:
Gateway Group, Inc.
Cody Slach
1-949-574-3860
NATR@gateway-grp.com
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Amounts in thousands, except per share information) (Unaudited) | |||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||
| Net sales | $ | 114,615 | $ | 111,202 | $ | 336,159 | $ | 336,384 | |||||
| Cost of sales | 32,856 | 29,964 | 96,535 | 93,580 | |||||||||
| Gross profit | 81,759 | 81,238 | 239,624 | 242,804 | |||||||||
| Operating expenses: | |||||||||||||
| Volume incentives | 35,521 | 34,118 | 103,784 | 102,560 | |||||||||
| Selling, general and administrative | 40,954 | 41,288 | 120,295 | 127,203 | |||||||||
| Operating income | 5,284 | 5,832 | 15,545 | 13,041 | |||||||||
| Other income (loss), net | 2,615 | (927 | ) | 1,432 | (500 | ) | |||||||
| Income before provision for income taxes | 7,899 | 4,905 | 16,977 | 12,541 | |||||||||
| Provision for income taxes | 3,253 | 1,763 | 8,353 | 5,469 | |||||||||
| Net income | 4,646 | 3,142 | 8,624 | 7,072 | |||||||||
| Net income attributable to noncontrolling interests | 299 | 310 | 607 | 958 | |||||||||
| Net income attributable to common shareholders | $ | 4,347 | $ | 2,832 | $ | 8,017 | $ | 6,114 | |||||
| Basic and diluted net income per common share: | |||||||||||||
| Basic earnings per share attributable to common shareholders | $ | 0.23 | $ | 0.15 | $ | 0.43 | $ | 0.32 | |||||
| Diluted earnings per share attributable to common shareholders | $ | 0.23 | $ | 0.15 | $ | 0.42 | $ | 0.31 | |||||
| Weighted average basic common shares outstanding | 18,512 | 19,133 | 18,661 | 19,093 | |||||||||
| Weighted average diluted common shares outstanding | 18,890 | 19,492 | 19,115 | 19,450 | |||||||||
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands) (Unaudited) | |||||||
| September 30, 2024 | December 31, 2023 | ||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 78,704 | $ | 82,373 | |||
| Accounts receivable, net of allowance for doubtful accounts of | 11,396 | 8,827 | |||||
| Inventories | 62,298 | 66,895 | |||||
| Prepaid expenses and other | 11,131 | 7,722 | |||||
| Total current assets | 163,529 | 165,817 | |||||
| Property, plant and equipment, net | 41,994 | 45,000 | |||||
| Operating lease right-of-use assets | 13,815 | 13,361 | |||||
| Investment securities - trading | 892 | 747 | |||||
| Deferred income tax assets | 14,941 | 15,064 | |||||
| Other assets | 10,162 | 9,784 | |||||
| Total assets | $ | 245,333 | $ | 249,773 | |||
| Liabilities and Shareholders’ Equity | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 8,875 | $ | 7,910 | |||
| Accrued volume incentives and service fees | 21,958 | 22,922 | |||||
| Accrued liabilities | 24,011 | 33,162 | |||||
| Deferred revenue | 1,747 | 1,794 | |||||
| Income taxes payable | 6,522 | 6,418 | |||||
| Current portion of operating lease liabilities | 4,037 | 4,547 | |||||
| Total current liabilities | 67,150 | 76,753 | |||||
| Liability related to unrecognized tax benefits | 651 | 312 | |||||
| Long-term portion of operating lease liabilities | 11,237 | 10,376 | |||||
| Deferred compensation payable | 892 | 747 | |||||
| Deferred income tax liabilities | 1,346 | 1,401 | |||||
| Other liabilities | 1,440 | 644 | |||||
| Total liabilities | 82,716 | 90,233 | |||||
| Shareholders’ equity: | |||||||
| Common stock, no par value, 50,000 shares authorized, 18,498 and 18,875 shares issued and outstanding, respectively | 113,946 | 119,694 | |||||
| Retained earnings | 57,728 | 49,711 | |||||
| Noncontrolling interest | 6,089 | 5,482 | |||||
| Accumulated other comprehensive loss | (15,146 | ) | (15,347 | ) | |||
| Total shareholders’ equity | 162,617 | 159,540 | |||||
| Total liabilities and shareholders’ equity | $ | 245,333 | $ | 249,773 | |||
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) (Unaudited) | |||||||
| Nine Months Ended September 30, | |||||||
| 2024 | 2023 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income | $ | 8,624 | $ | 7,072 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Provision for doubtful accounts | — | 45 | |||||
| Depreciation and amortization | 10,195 | 8,763 | |||||
| Non-cash lease expense | 4,386 | 3,290 | |||||
| Share-based compensation expense | 3,580 | 3,790 | |||||
| Loss on sale of property, plant and equipment | 1,330 | — | |||||
| Deferred income taxes | 26 | (2,986 | ) | ||||
| Purchase of trading investment securities | (126 | ) | — | ||||
| Proceeds from sale of trading investment securities | 95 | 76 | |||||
| Realized and unrealized gains on investments | (113 | ) | (66 | ) | |||
| Foreign exchange losses (gains) | (1,111 | ) | 687 | ||||
| Changes in assets and liabilities: | |||||||
| Accounts receivable | (2,563 | ) | 3,955 | ||||
| Inventories | 4,392 | 423 | |||||
| Prepaid expenses and other current assets | (3,588 | ) | (1,091 | ) | |||
| Other assets | (444 | ) | 733 | ||||
| Accounts payable | 838 | 917 | |||||
| Accrued volume incentives and service fees | (876 | ) | 2,102 | ||||
| Accrued liabilities | (7,759 | ) | 7,416 | ||||
| Deferred revenue | (46 | ) | (877 | ) | |||
| Lease liabilities | (4,492 | ) | (3,414 | ) | |||
| Income taxes payable | 180 | 803 | |||||
| Liability related to unrecognized tax benefits | 442 | — | |||||
| Deferred compensation payable | 144 | (10 | ) | ||||
| Net cash provided by operating activities | 13,114 | 31,628 | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property, plant and equipment | (8,776 | ) | (9,230 | ) | |||
| Net cash used in investing activities | (8,776 | ) | (9,230 | ) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Principal payments of long-term debt | — | (958 | ) | ||||
| Proceeds from revolving credit facility | 40,172 | 13,503 | |||||
| Principal payments of revolving credit facility | (40,172 | ) | (13,503 | ) | |||
| Payments related to tax withholding for net-share settled equity awards | (893 | ) | (179 | ) | |||
| Repurchase of common stock | (8,436 | ) | (2,228 | ) | |||
| Net cash used in financing activities | (9,329 | ) | (3,365 | ) | |||
| Effect of exchange rates on cash and cash equivalents | 1,322 | (3,029 | ) | ||||
| Net increase (decrease) in cash and cash equivalents | (3,669 | ) | 16,004 | ||||
| Cash and cash equivalents at the beginning of the period | 82,373 | 60,032 | |||||
| Cash and cash equivalents at the end of the period | $ | 78,704 | $ | 76,036 | |||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||||
| Cash paid for income taxes, net of refunds | $ | 9,782 | $ | 7,460 | |||
| Cash paid for interest | 141 | 124 | |||||
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (Amounts in thousands) (Unaudited) | ||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||
| Net income | $ | 4,646 | $ | 3,142 | $ | 8,624 | $ | 7,072 | ||||||
| Adjustments: | ||||||||||||||
| Depreciation and amortization | 3,536 | 3,125 | 10,195 | 8,763 | ||||||||||
| Share-based compensation expense | 950 | 1,295 | 3,580 | 3,790 | ||||||||||
| Other (income) loss, net* | (2,615 | ) | 927 | (1,432 | ) | 500 | ||||||||
| Provision for income taxes | 3,253 | 1,763 | 8,353 | 5,469 | ||||||||||
| Other adjustments (1) | 957 | — | 957 | 5,098 | ||||||||||
| Adjusted EBITDA | $ | 10,727 | $ | 10,252 | $ | 30,277 | $ | 30,692 | ||||||
| (1) Other adjustments | ||||||||||||||
| Loss on sale of property and equipment | $ | 1,330 | $ | — | $ | 1,330 | $ | — | ||||||
| Restructuring and other related expenses | 619 | — | 619 | — | ||||||||||
| Charge related to Japan loss | $ | — | $ | — | $ | — | $ | 5,847 | ||||||
| VAT refunds | (992 | ) | — | (992 | ) | (749 | ) | |||||||
| Total adjustments | $ | 957 | $ | — | $ | 957 | $ | 5,098 | ||||||
* Other (income) loss, net is primarily comprised of foreign exchange (gains) losses, interest income, and interest expense.
| NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME and NON-GAAP ADJUSTED EPS (Amounts in thousands) (Unaudited) | ||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||
| Net income | $ | 4,646 | $ | 3,142 | $ | 8,624 | $ | 7,072 | ||||||
| Adjustments: | ||||||||||||||
| Loss on sale of property and equipment | 1,330 | — | 1,330 | — | ||||||||||
| Restructuring and other related expenses | 619 | — | 619 | — | ||||||||||
| Charge related to Japan loss | — | — | — | 5,847 | ||||||||||
| VAT Refund | (992 | ) | — | (992 | ) | (749 | ) | |||||||
| Tax impact of adjustments | (155 | ) | — | (155 | ) | (1,462 | ) | |||||||
| Total adjustments | 802 | — | 802 | 3,636 | ||||||||||
| Non-GAAP net income | $ | 5,448 | $ | 3,142 | $ | 9,426 | $ | 10,708 | ||||||
| Reported income attributable to common shareholders | $ | 4,347 | $ | 2,832 | $ | 8,017 | $ | 6,114 | ||||||
| Total adjustments | 802 | — | 802 | 3,636 | ||||||||||
| Non-GAAP net income attributable to common shareholders | $ | 5,149 | $ | 2,832 | $ | 8,819 | $ | 9,750 | ||||||
| Basic income per share, as reported | $ | 0.23 | $ | 0.15 | $ | 0.43 | $ | 0.32 | ||||||
| Total adjustments, net of tax | 0.04 | — | 0.04 | 0.19 | ||||||||||
| Basic income per share, as adjusted | $ | 0.27 | $ | 0.15 | $ | 0.47 | $ | 0.51 | ||||||
| Diluted income per share, as reported | $ | 0.23 | $ | 0.15 | $ | 0.42 | $ | 0.31 | ||||||
| Total adjustments, net of tax | 0.04 | — | 0.04 | 0.19 | ||||||||||
| Diluted income per share, as adjusted | $ | 0.27 | $ | 0.15 | $ | 0.46 | $ | 0.50 | ||||||
FAQ
What was Nature's Sunshine (NATR) revenue in Q3 2024?
What is Nature's Sunshine (NATR) earnings per share for Q3 2024?
What is Nature's Sunshine (NATR) full-year 2024 guidance?
How much cash does Nature's Sunshine (NATR) have as of Q3 2024?
